This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Forma gives Genentech option to buy cancer candidate
Roche’s Genentech Inc. has received an exclusive global option to acquire a preclinical cancer candidate from Forma Therapeutics Inc. (addressing challenging oncology drug targets). NOTE: according to PharmaProjects, the candidate is a small-molecule nicotinamide phosphoribosyltransferase inhibitor.
R+D and Marketing-Licensing
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?